April 2026 Sexual Wellness & Sex Tech Brief: 7 Stories to Watch
A weekly digest covering regulatory updates, industry developments, safety alerts, market research, and Canadian local news across the sexual wellness and sex tech sectors. Compiled by the Dr.Chen Wellness Editorial Team.
This April 2026 issue spans five reporting categories: regulatory and safety enforcement from Health Canada; a landmark new clinical guideline from the Public Health Agency of Canada on STI post-exposure prevention; two policy developments shaping how Canadians talk about and access sexual health services; a well-funded Canadian femtech startup addressing the reproductive health care gap; a new global market forecast for women's health technology; and two industry stories — one about how a major intimate wellness brand is embedding clinical expertise at the brand level, and one about a new class of intimate aftercare products entering mainstream retail. Together, these stories reflect a sector increasingly shaped by science, public health infrastructure, and consumer demand for evidence-based products.
1. Health Canada Maintains Active Advisory on Unauthorized Sexual Enhancement Products [OFFICIAL — CANADA / SAFETY]
Fact: Health Canada continues to maintain an active public advisory warning Canadians about unauthorized sexual enhancement products that may pose serious health risks. A five-month border-enforcement operation conducted between December 2024 and May 2025 intercepted 539 packages, of which 69% were identified as counterfeit or unauthorized sexual enhancement medications. The advisory, posted on the Government of Canada Recalls and Safety Alerts database, remains in force as of April 2026.
Background: Unauthorized sexual enhancement products are a recurring area of enforcement for Health Canada. These products are typically sold online or in retail environments without a Drug Identification Number (DIN) and may contain undeclared prescription-strength ingredients such as sildenafil or tadalafil — substances that require a physician's prescription and carry contraindications for users taking nitrates or blood pressure medications.
Significance: For Canadian consumers, the continued advisory underscores that the unauthorized enhancement product market remains large and active. This can reasonably be viewed as evidence that existing enforcement capacity, while capable of large seizure operations, has not eliminated the supply. Canadian retailers and consumers purchasing intimate enhancement products should verify DIN numbers on all ingestible or topical sexual health products before purchase or stocking decisions.
2. Public Health Agency of Canada Issues New Doxy-PEP Recommendations for Bacterial STI Prevention [OFFICIAL — CANADA / HEALTH]
Fact: The Public Health Agency of Canada (PHAC) has published national recommendations on the use of doxycycline post-exposure prophylaxis (Doxy-PEP) for the prevention of bacterial sexually transmitted infections including chlamydia, syphilis, and — with caveats — gonorrhea. The guideline recommends a single 200 mg oral dose taken within 72 hours of a condomless sexual exposure for cisgender gay, bisexual, and other men who have sex with men (GBMSM) and transgender women at elevated STI risk. CATIE, Canada's knowledge exchange organization, published a summary of the new guidelines on February 17, 2026.
Background: Doxy-PEP has been under evaluation in multiple jurisdictions as bacterial STI rates — particularly syphilis — continue to rise in Canada and globally. The new PHAC guidance represents the first formal national recommendation framework for this intervention in Canada, a development that has been anticipated by sexual health clinicians and advocates since promising clinical trial data began emerging in 2023 and 2024.
Significance: The PHAC recommendations mark a significant evolution in Canadian STI prevention policy. However, the guidelines explicitly note that 47.3% of gonorrhea cases in Canada in 2023 demonstrated tetracycline resistance (rising to 56.7% among GBMSM cases), meaning Doxy-PEP is unlikely to be fully effective against gonorrhea for a substantial proportion of exposures. This may suggest that Doxy-PEP should be understood as a complementary tool rather than a replacement for condom use and routine STI screening — a distinction that sexual health educators, clinics, and consumer-facing wellness platforms in Canada will need to communicate clearly.
3. Statistics Canada Adds Sexual Orientation Question to 2026 Census for the First Time [OFFICIAL — CANADA]
Fact: Statistics Canada will include a question on sexual orientation in the 2026 Census of Population for the first time in Canadian history. The long-form questionnaire, distributed to approximately 25% of Canadian households starting in May 2026, will ask respondents aged 15 and older: "What is this person's sexual orientation?" with response options including heterosexual, lesbian or gay, bisexual or pansexual, and an open-text field to specify other identities. The change was reported by CBC News and confirmed in Statistics Canada's report on content changes for the 2026 Census.
Background: The addition addresses a long-standing gap in Canadian population data. Without reliable national data on sexual orientation, researchers and policymakers have faced significant limitations in tracking socioeconomic disparities affecting 2SLGBTQ+ communities in areas such as housing, employment, poverty rates, and health access. Canada's approach aligns with census methodology already used in England, Wales, Scotland, Northern Ireland, and New Zealand.
Significance: The inclusion of sexual orientation data in the national census represents a structural investment in evidence-based policymaking for Canada's 2SLGBTQ+ population. (Editorial note:) For the sexual health and wellness sector, this data infrastructure may over time support more targeted public health programming, consumer research, and funding allocation directed at communities that have historically been underserved or underrepresented in health research — including areas directly relevant to sexual wellness product access and sexual health education.
4. Ontario AI Startup myStoria Closes $1.625M Seed to Build Reproductive Health Care Coordination Platform [CANADA / TECH]
Fact: Kitchener, Ontario-based health-tech startup myStoria closed a $1.625 million seed funding round on March 31, 2026, led by Graphite Ventures with participation from Conexus Venture Capital, the Adrenaline Fund, Phoenix Fire Fund, and angel investors. The company is building a mobile-first AI-powered care coordination platform for reproductive health patients, described as a "Context Engine" that organizes health history — including documents, audio recordings, photos, and symptom logs — into structured formats optimized for AI-assisted guidance. HIT Consultant reported the funding on March 31, 2026.
Background: myStoria's platform is designed to address fragmentation in Canadian reproductive health care, where conditions such as endometriosis can take seven to ten years to diagnose due to symptom dismissal and lack of care continuity. The platform offers a free tier for AI-powered guidance and health record organization, with paid tiers starting at $19 per month for access to trained human professionals. The company plans to expand beyond fertility navigation to cover painful periods, PCOS, perimenopause, and hormonal health.
Significance: The myStoria raise is notable as one of the first Canadian femtech seed rounds of 2026 to be publicly announced, and it signals continued investor interest in AI-mediated solutions to care fragmentation in reproductive health. This may suggest a growing appetite among Canadian venture investors for health infrastructure plays in women's health — particularly platforms that address diagnostic delays and patient advocacy gaps disproportionately experienced by people with uteruses. For clinics, pelvic health practitioners, and sexual wellness educators in Canada, platforms like myStoria represent a new category of patient-facing technology that may complement broader sexual health service delivery.
5. FemTech Global Market Projected to Reach USD 296.85 Billion by 2035 [RESEARCH]
Fact: A market research report published on GlobeNewswire on March 5, 2026 projects that the global FemTech market will reach USD 296.85 billion by 2035, driven primarily by increasing smartphone penetration and the expanding role of digital platforms in women's health management. The report identifies mobile health applications, wearable devices for menstrual and fertility tracking, and AI-assisted diagnostics as the primary growth vectors across the forecast period.
Background: FemTech — a category encompassing technology products and services designed to address health conditions or needs specific to people with female biology — has grown rapidly since the term was popularized in the mid-2010s. The category spans reproductive health apps, pelvic floor devices, hormonal health monitoring tools, and increasingly, sexual wellness technology. Smartphone penetration is cited as a structural driver because mobile platforms enable both consumer health tracking and practitioner-to-patient service delivery at scale.
Significance: A projected market of nearly USD 297 billion by 2035 positions FemTech as one of the most significant growth segments in the global health technology landscape. This can reasonably be viewed as reflecting a broader normalization of women's health as a legitimate technology investment category — a shift that, when combined with structural data investments like the Statistics Canada census update reported in this issue, points toward an ecosystem increasingly willing to fund, measure, and design services for populations historically underserved by mainstream health systems.
6. Beacon Wellness Brands Launches plusOne Wellness Collective Clinical Advisory Panel [INDUSTRY]
Fact: Beacon Wellness Brands, the parent company of the plusOne intimate wellness brand, announced the formation of the 2026 plusOne Wellness Collective via PR Newswire. The interdisciplinary advisory panel includes Dr. Heather Bartos, MD, an OB-GYN and menopause specialist, alongside practitioners in sex education, gynecology, pelvic floor therapy, and sexual health counselling. The panel's stated mandate is to ground the plusOne brand in peer-reviewed medical expertise and to advance culturally relevant consumer education around intimate wellness.
Background: Beacon Wellness Brands operates in the mainstream consumer retail space, with plusOne products distributed through major US and Canadian retail chains. The formation of a formal clinical advisory structure is part of a broader industry trend in which sexual wellness brands are seeking to differentiate through medical and scientific credibility rather than product features alone — a strategy increasingly expected by retail buyers and health-conscious consumers.
Significance: The launch of a structured clinical advisory panel by a brand with mainstream retail distribution reflects an industry-wide shift toward medicalization of the sexual wellness category. (Editorial note:) For Canadian retailers stocking intimate wellness products, this type of brand-level investment in clinical credibility may become an important factor in category selection — particularly as consumers increasingly seek products backed by professional endorsement rather than marketing language alone. The inclusion of pelvic floor and menopause expertise is particularly significant given the growing retail interest in femtech-adjacent intimate wellness.
7. Dr. Tush's Launches Intimate Aftercare Hydrogel for Post-Intimacy Recovery [SEX TECH / BRAND]
Fact: Dr. Tush's, a US-based intimate care brand manufacturing in an FDA-certified facility, announced the retail availability of "After Vajay Play" on March 27, 2026, as reported by JRL Charts. The product is a pH-balanced intimate aftercare hydrogel formulated with peppermint and vitamin E, designed to deliver cooling relief and restorative hydration following intimate activity. It is also marketed for post-shaving and post-waxing intimate skin care. The product is vegan and cruelty-free, and is available through Amazon and the brand's direct-to-consumer website.
Background: Intimate aftercare as a distinct product category has been gaining shelf space and consumer awareness alongside the broader mainstreaming of sexual wellness retail. Aftercare products — designed to address skin sensitivity, pH balance, and hydration following sexual activity — represent a relatively new segment that bridges personal care and sexual wellness, enabling distribution through both mass-market and specialty intimate wellness retail channels.
Significance: The launch of products like "After Vajay Play" reflects an expanding definition of intimate wellness that extends beyond the act of sex itself to encompass recovery and aftercare as part of a holistic sexual health routine. This may suggest growing consumer willingness to invest in the full arc of intimate wellness — not just devices and lubricants, but purpose-formulated recovery products. For Canadian retailers and buyers, the aftercare segment may represent a lower-barrier, higher-margin category adjacent to established personal care, with few regulatory hurdles and strong potential for educational upsell.
Editors' Note: What This Month's Stories Mean Together
Three cross-cutting themes emerge from this issue. First, there is a deepening institutionalization of sexual health within Canadian public policy infrastructure — from PHAC's first formal national Doxy-PEP guideline to Statistics Canada embedding sexual orientation into the census for the first time. These are not isolated policy gestures; they represent a cumulative investment in the data and clinical frameworks needed to address sexual health as a serious public health domain rather than a peripheral or stigmatized one.
Second, the private sector is moving to match that institutional seriousness. The myStoria seed round, the FemTech market forecast, and the Beacon Wellness Brands advisory panel all reflect an industry aligning around evidence, credentials, and infrastructure — not just products. The message to retailers and brand partners is consistent: clinical credibility is becoming table stakes in the sexual wellness space, not a differentiator.
Third, consumer expectations are broadening. The aftercare product launch from Dr. Tush's is a small but meaningful indicator that consumers are beginning to conceptualize intimate wellness across a longer timeline — before, during, and after intimacy — creating new retail and educational opportunities for wellness brands and retailers willing to meet them there. These three themes — public health infrastructure, private sector credibility, and expanding consumer expectations — together suggest a sector that is maturing rapidly and in multiple dimensions at once.
— Dr.Chen Wellness Editorial Team, April 2026
References
- Health Canada. (2026, ongoing). Unauthorized sexual enhancement products may pose serious health risks. Government of Canada Recalls and Safety Alerts. https://recalls-rappels.canada.ca/en/alert-recall/unauthorized-sexual-enhancement-products-may-pose-serious-health-risks
- Public Health Agency of Canada. (2026). Recommendations on the use of prophylactic doxycycline for the prevention of bacterial STI. Canada.ca. https://www.canada.ca/en/public-health/services/infectious-diseases/sexual-health-sexually-transmitted-infections/canadian-guidelines/national-advisory-committee-stbbi/recommendations-prophylactic-doxycycline-prevention-bacterial-sti-chlamydia-gonorrhea-syphilis.html
- CBC News. (2026). Sexual orientation question to appear on census for first time in 2026. CBC. https://www.cbc.ca/news/politics/canadian-census-sexual-orientation-1.7569720
- HIT Consultant. (2026, March 31). myStoria Secures $1.6M to Launch AI-Powered Reproductive Health Platform. HIT Consultant. https://hitconsultant.net/2026/03/31/mystoria-1-6m-seed-funding-ai-patient-care-coordination-reproductive-health/
- GlobeNewswire. (2026, March 5). FemTech Market Size to Reach USD 296.85 Billion by 2035; Increasing Smartphone Penetration to Propel Market Growth Globally. GlobeNewswire. https://www.globenewswire.com/news-release/2026/03/05/3249925/0/en/FemTech-Market-Size-to-Reach-USD-296-85-Billion-by-2035-Increasing-Smartphone-Penetration-to-Propel-Market-Growth-Globally.html
- PR Newswire. (2026). Beacon Wellness Brands Announces The 2026 plusOne Wellness Collective. PR Newswire. https://www.prnewswire.com/news-releases/beacon-wellness-brands-announces-the-2026-plusone-wellness-collective-302695536.html
- JRL Charts. (2026, March 27). After Vajay Play by Dr. Tush's Is the Must-Stock Intimate Wellness Aftercare Solution. JRL Charts. https://jrlcharts.com/2026/03/27/after-vajay-play-by-dr-tushs-is-the-must-stock-intimate-wellness-aftercare-solution/
